---
title: "New Hope Corporation Limited (NHPEF) was upgraded to a Buy Rating at Macquarie"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/280927260.md"
description: "New Hope Corporation Limited (NHPEF) has been upgraded to a Buy rating by Macquarie, with a price target of A$7.00. Additionally, TipRanks also issued a Buy rating for the company. However, Jefferies maintained a Hold rating on March 18."
datetime: "2026-03-29T23:55:08.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/280927260.md)
  - [en](https://longbridge.com/en/news/280927260.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/280927260.md)
generator: "portal-rs"
---

# New Hope Corporation Limited (NHPEF) was upgraded to a Buy Rating at Macquarie

New Hope Corporation Limited received a Buy rating and a A$7.00 price target from Macquarie analyst today.

### End of Quarter Sale - 50% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

In addition to Macquarie, New Hope Corporation Limited also received a Buy from TipRanks – xAI’s xAi Coal in a report issued yesterday. However, on March 18, Jefferies maintained a Hold rating on New Hope Corporation Limited (Other OTC: NHPEF).

### Related Stocks

- [NHC.AU](https://longbridge.com/en/quote/NHC.AU.md)

## Related News & Research

- [UBS Remains a Buy on Westgold Resources (WGXRF)](https://longbridge.com/en/news/298147187.md)
- [PRECIOUS-Gold little changed as markets await key US inflation data](https://longbridge.com/en/news/298146831.md)
- [Ord Minnett Keeps Their Sell Rating on Paladin Energy Ltd (PALAF)](https://longbridge.com/en/news/298156101.md)
- [UBS upgrades Regis Resources Limited (RGRNF) to a Hold](https://longbridge.com/en/news/298145159.md)
- [Cyclezyme to buy Ragn-Sells melanin patent, pays via shares for 7.9% stake](https://longbridge.com/en/news/298137821.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**